Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A

Fig. 2

miR-98-5p targets CDKN1A to inhibit CDKN1A expression. a The expression of related miRs in the CAF-derived exosomes as detected by RT-qPCR. b The binding sites between CDKN1A and miR-98-5p predicted by the TargetScan website. c The binding of miR-98-5p to CDKN1A as verified by dual luciferase reporter assay. d The expression of CDKN1A in OC cells after treatment of miR-98-5p mimic as detected by RT-qPCR. e The expression of CDKN1A in OC cells after treatment of miR-98-5p mimic as detected by Western blot analysis. f Statistical analysis for e. g Pearson’s correlation analysis of the correlation between the expression of miR-98-5p and CDKN1A in OC cells. *p < 0.05 vs. has-miR-98-5p or the treatment of mimic-NC. These data were measurement data, expressed as mean ± standard deviation. Data between two groups were compared using unpaired t-test. Data among multiple groups were compared using one-way analysis of variance and further analyzed with Tukey’s post hoc test. The correlation between two indices was analyzed using Pearson’s correlation analysis. The experiment was repeated three times

Back to article page